A single-institution Wilms' tumor and localized neuroblastoma series

C. Boglino, A. Inserra, S. Madafferi, A. Jenkner, F. Diomedi Camassei, R. Boldrini, A. Donfrancesco

Research output: Contribution to journalArticle

Abstract

Since January 1980, 120 children affected by Wilms' tumor have been treated at Bambino Gesù, mostly with multimodality treatment according to Société Internationale d'Oncologie Pediatrique (SIOP) protocols, including chemotherapy, surgery and radiotherapy in selected cases. This treatment approach emphasizes the role of preoperative (neoadjuvant) chemotherapy as opposed to the approach favored by the National Wilms' Tumor Study, which is focused on optimizing post-operative chemotherapy after primary surgery. Thus, using SIOP guidelines, staging occurs at the time of surgery, after chemotherapy administration. These differences will constitute the baseline for a comparison between the two experiences. Bilaterality, nephroblastomatosis, partial nephrectomy in unilateral Wilms' tumor and thrombosis of the vena cava are the main topics discussed. For the present study, the analysis was restricted to 98 consecutive cases diagnosed until December 1999, for whom at least 24 mo of follow-up is available. The more recent experience of treating resectable neuroblastoma in cooperative studies dates back to 1979, when the first Italian Cooperative Group Neuroblastoma protocol was introduced. This experience was continued within the frame of the first Localized Neuroblastoma European Study Group protocol (LNESG 94), and will be compared to North American Cooperative Group approaches and outcomes. Preoperative evaluation of surgical risk factors, intraoperative complications and their management, and long-term outcome will be discussed.

Original languageEnglish
Pages (from-to)74-77
Number of pages4
JournalActa Paediatrica, International Journal of Paediatrics, Supplement
Volume93
Issue number445
Publication statusPublished - May 2004

Fingerprint

Wilms Tumor
Neuroblastoma
Drug Therapy
Venae Cavae
Intraoperative Complications
Nephrectomy
Thrombosis
Radiotherapy
Guidelines
Therapeutics

Keywords

  • Child
  • Neuroblastoma
  • Wilms' tumor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

A single-institution Wilms' tumor and localized neuroblastoma series. / Boglino, C.; Inserra, A.; Madafferi, S.; Jenkner, A.; Diomedi Camassei, F.; Boldrini, R.; Donfrancesco, A.

In: Acta Paediatrica, International Journal of Paediatrics, Supplement, Vol. 93, No. 445, 05.2004, p. 74-77.

Research output: Contribution to journalArticle

@article{8933e153a72043c4bdf20e4bd4094bd0,
title = "A single-institution Wilms' tumor and localized neuroblastoma series",
abstract = "Since January 1980, 120 children affected by Wilms' tumor have been treated at Bambino Ges{\`u}, mostly with multimodality treatment according to Soci{\'e}t{\'e} Internationale d'Oncologie Pediatrique (SIOP) protocols, including chemotherapy, surgery and radiotherapy in selected cases. This treatment approach emphasizes the role of preoperative (neoadjuvant) chemotherapy as opposed to the approach favored by the National Wilms' Tumor Study, which is focused on optimizing post-operative chemotherapy after primary surgery. Thus, using SIOP guidelines, staging occurs at the time of surgery, after chemotherapy administration. These differences will constitute the baseline for a comparison between the two experiences. Bilaterality, nephroblastomatosis, partial nephrectomy in unilateral Wilms' tumor and thrombosis of the vena cava are the main topics discussed. For the present study, the analysis was restricted to 98 consecutive cases diagnosed until December 1999, for whom at least 24 mo of follow-up is available. The more recent experience of treating resectable neuroblastoma in cooperative studies dates back to 1979, when the first Italian Cooperative Group Neuroblastoma protocol was introduced. This experience was continued within the frame of the first Localized Neuroblastoma European Study Group protocol (LNESG 94), and will be compared to North American Cooperative Group approaches and outcomes. Preoperative evaluation of surgical risk factors, intraoperative complications and their management, and long-term outcome will be discussed.",
keywords = "Child, Neuroblastoma, Wilms' tumor",
author = "C. Boglino and A. Inserra and S. Madafferi and A. Jenkner and {Diomedi Camassei}, F. and R. Boldrini and A. Donfrancesco",
year = "2004",
month = "5",
language = "English",
volume = "93",
pages = "74--77",
journal = "Acta Paediatrica, International Journal of Paediatrics, Supplement",
issn = "0803-5326",
publisher = "Taylor and Francis Ltd.",
number = "445",

}

TY - JOUR

T1 - A single-institution Wilms' tumor and localized neuroblastoma series

AU - Boglino, C.

AU - Inserra, A.

AU - Madafferi, S.

AU - Jenkner, A.

AU - Diomedi Camassei, F.

AU - Boldrini, R.

AU - Donfrancesco, A.

PY - 2004/5

Y1 - 2004/5

N2 - Since January 1980, 120 children affected by Wilms' tumor have been treated at Bambino Gesù, mostly with multimodality treatment according to Société Internationale d'Oncologie Pediatrique (SIOP) protocols, including chemotherapy, surgery and radiotherapy in selected cases. This treatment approach emphasizes the role of preoperative (neoadjuvant) chemotherapy as opposed to the approach favored by the National Wilms' Tumor Study, which is focused on optimizing post-operative chemotherapy after primary surgery. Thus, using SIOP guidelines, staging occurs at the time of surgery, after chemotherapy administration. These differences will constitute the baseline for a comparison between the two experiences. Bilaterality, nephroblastomatosis, partial nephrectomy in unilateral Wilms' tumor and thrombosis of the vena cava are the main topics discussed. For the present study, the analysis was restricted to 98 consecutive cases diagnosed until December 1999, for whom at least 24 mo of follow-up is available. The more recent experience of treating resectable neuroblastoma in cooperative studies dates back to 1979, when the first Italian Cooperative Group Neuroblastoma protocol was introduced. This experience was continued within the frame of the first Localized Neuroblastoma European Study Group protocol (LNESG 94), and will be compared to North American Cooperative Group approaches and outcomes. Preoperative evaluation of surgical risk factors, intraoperative complications and their management, and long-term outcome will be discussed.

AB - Since January 1980, 120 children affected by Wilms' tumor have been treated at Bambino Gesù, mostly with multimodality treatment according to Société Internationale d'Oncologie Pediatrique (SIOP) protocols, including chemotherapy, surgery and radiotherapy in selected cases. This treatment approach emphasizes the role of preoperative (neoadjuvant) chemotherapy as opposed to the approach favored by the National Wilms' Tumor Study, which is focused on optimizing post-operative chemotherapy after primary surgery. Thus, using SIOP guidelines, staging occurs at the time of surgery, after chemotherapy administration. These differences will constitute the baseline for a comparison between the two experiences. Bilaterality, nephroblastomatosis, partial nephrectomy in unilateral Wilms' tumor and thrombosis of the vena cava are the main topics discussed. For the present study, the analysis was restricted to 98 consecutive cases diagnosed until December 1999, for whom at least 24 mo of follow-up is available. The more recent experience of treating resectable neuroblastoma in cooperative studies dates back to 1979, when the first Italian Cooperative Group Neuroblastoma protocol was introduced. This experience was continued within the frame of the first Localized Neuroblastoma European Study Group protocol (LNESG 94), and will be compared to North American Cooperative Group approaches and outcomes. Preoperative evaluation of surgical risk factors, intraoperative complications and their management, and long-term outcome will be discussed.

KW - Child

KW - Neuroblastoma

KW - Wilms' tumor

UR - http://www.scopus.com/inward/record.url?scp=2342529873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342529873&partnerID=8YFLogxK

M3 - Article

C2 - 15176726

AN - SCOPUS:2342529873

VL - 93

SP - 74

EP - 77

JO - Acta Paediatrica, International Journal of Paediatrics, Supplement

JF - Acta Paediatrica, International Journal of Paediatrics, Supplement

SN - 0803-5326

IS - 445

ER -